PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ecamEvidence-based Complementary and Alternative Medicine : eCAM
 
Evid Based Complement Alternat Med. 2017; 2017: 5748256.
Published online 2017 August 21. doi:  10.1155/2017/5748256
PMCID: PMC5585606

Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview from Traditional Use to Pharmacological Evidence

Abstract

Snakebites are a serious problem in public health due to their high morbimortality. Most of snake venoms produce intense local tissue damage, which could lead to temporary or permanent disability in victims. The available specific treatment is the antivenom serum therapy, whose effectiveness is reduced against these effects. Thus, the search for complementary alternatives for snakebite treatment is relevant. There are several reports of the popular use of medicinal plants against snakebites worldwide. In recent years, many studies have been published giving pharmacological evidence of benefits of several vegetal species against local effects induced by a broad range of snake venoms, including inhibitory potential against hyaluronidase, phospholipase, proteolytic, hemorrhagic, myotoxic, and edematogenic activities. In this context, this review aimed to provide an updated overview of medicinal plants used popularly as antiophidic agents and discuss the main species with pharmacological studies supporting the uses, with emphasis on plants inhibiting local effects of snake envenomation. The present review provides an updated scenario and insights into future research aiming at validation of medicinal plants as antiophidic agents and strengthens the potentiality of ethnopharmacology as a tool for design of potent inhibitors and/or development of herbal medicines against venom toxins, especially local tissue damage.

1. Introduction

Snakebites are a serious public health problem in many regions around the world, particularly in Africa, Asia, Latin America, and parts of Oceania [1]. Conservative data indicate that, worldwide, there are between 1.2 and 5.5 million snakebites every year, leading to 25,000 to 125,000 deaths [2]. Despite its significant impact on human health, this condition remains largely neglected by national and international health authorities, funding agencies, pharmaceutical companies, patients' organizations, and health advocacy groups [1]. Thus, snake envenomation is included since 2009 in World Health Organization (WHO) list of Neglected Tropical Diseases (NTDs) [3]. Envenoming and deaths resulting from snakebites are a particularly important public health problem in the rural tropics. Populations in these regions experience high morbidity and mortality because of poor access to health services, which are often suboptimal, as well as other NTDs, which are associated with poverty [3, 4].

Snakes with major clinical importance belong to the families Elapidae (African and Asian cobras, Asian kraits, African mambas, American coral snakes, Australian and New Guinean venomous snakes, and sea snakes) and Viperidae (Old World vipers, American rattlesnakes and pit vipers, and Asian pit vipers) [5]. After production, snake venom is injected in the victim via tubular or channeled fangs [6]. Biochemically, venoms are complex mixtures of pharmacologically active proteins and polypeptides, acting in concert to help in immobilizing the prey [7]. The most common toxins in snake venoms are snake venom metalloproteinases (SVMPs), phospholipases A2 (PLA2s), snake venom serine proteinases (SVSPs), acetylcholinesterase (AChE), L-amino acid oxidases (LAAOs), nucleotidases, and snake venom hyaluronidases (SVHs) [7].

Biological properties of snake venom components are peculiar to each species, but in general, the main clinical effects of snake envenomation are immediate and prominent local tissue damage (including myonecrosis, dermonecrosis, hemorrhage, and edema), coagulation disorders (consumption coagulopathy and spontaneous systemic bleeding), cardiovascular alterations (hypotension, hypovolemic shock, and myocardial damage), renal alterations (which could evolve into acute kidney injure), neurotoxic action (descending paralysis, progressing from ptosis and external ophthalmoplegia to bulbar, respiratory muscle, and total flaccid paralysis), generalized rhabdomyolysis with myoglobinuria, and intravascular haemolysis [5, 8].

The only available specific treatment is the antivenom serum therapy, which consists of a pool of neutralizing immunoglobulins, or immunoglobulin fragments, purified from the plasma of animals hyperimmunized against snake venoms or specific toxins. Its effectiveness consists in its ability to provide to the patient antibodies with a high affinity to snake venom, aiming to eliminate the toxins responsible for toxicity of the envenoming, mitigating the progress of toxic effects induced by snake venom components [9]. However, the antivenom has some limitations, such as poor ability to treat local effects, risk of immunological reactions, high cost, and difficult access in some regions [810]. If antivenom administration is initiated rapidly after envenomation, neutralization of systemic effects is usually achieved successfully; however, neutralization of local tissue damage is more difficult [8]. Furthermore, the availability and accessibility of antivenoms is limited in many regions, such as Sub-Saharan Africa, Asia, and, to a lesser extent, Latin America, which could aggravate even more this picture [1]. Thus, this inability to treat local effects, as well as the increased time between accident and treatment, is the main reason for the temporary or permanent disability observed in many victims, which can lead to serious social, economic, and health negative impacts, given that most victims live in rural areas [3].

In this context, the search for complementary therapies to treat snakebites is relevant and medicinal plants could be highlighted as a rich source of natural inhibitors and pharmacologically active compounds [6, 1113]. There are several reports of the popular use of medicinal plants against snakebites around the world, especially in tropical and subtropical regions such as Asia, Africa, and South America [14, 15]. The rural and tribal people living in remote areas greatly depend on folk medicines for the treatment of bites from any venomous creatures [16]. The use of medicinal plants against snakebites is a historical practice throughout the human history, and this knowledge has been transferred among the rural communities from generation after generation [17]. Nowadays, these herbal antidotes used in folk traditional medicine gained much attention by toxinologists worldwide as a tool for design of potent inhibitors against snake venom toxins. The potential advantages of antiophidic plants are their possible low cost, easy access, stability at room temperature, and ability to neutralize a broad spectrum of toxins, including the local tissue damage [12, 1517].

So, the objective of this review is to provide an updated overview of medicinal plants used popularly as antiophidic and discuss the main species with pharmacological studies supporting the uses, with emphasis on plants inhibiting local effects of snake envenomation, since this is a critical effect of snake venoms that could lead to relevant sequel to victims. A review of the main botanical families popularly used as antiophidic is presented, including the main species and forms of popular use of them. Then, studies supporting their popular use are discussed, as well as the advantages of this kind of approach for treatment of snake venom accident.

2. Methodology

An extensive review of the literature was undertaken in different scientific sources, such as PubMed (https://www.ncbi.nlm.nih.gov/pubmed), Science Direct (http://www.sciencedirect.com/), Scopus (https://www.scopus.com/), Web of Science (http://www.webofknowledge.com/), “Literatura Latino-Americana e do Caribe em Ciências da Saúde” (LILACS) (http://lilacs.bvsalud.org/), Scientific Electronic Library Online (SciELO) (http://www.scielo.org/), Google Scholar (https://scholar.google.com.br/), Cochrane Library (http://www.cochranelibrary.com/), and Centre for Reviews and Dissemination (CRD) (http://www.crd.york.ac.uk/CRDWeb).

The study database included original articles published in peer-reviewed journals, as well as books, thesis, dissertations, patents, and other reports covering antiophidic plants (ethnopharmacological surveys, original articles, or reviews), dated until December 2016. For the online search, where applicable, the following search strategy was employed: (“plant” OR “plants” OR “plant extract” OR “vegetal” OR “vegetal species” OR “vegetal extract” OR “traditional medicine” OR “alternative medicine” OR “complementary therapy” OR “natural medicine” OR “ethnopharmacology” OR “ethnobotany” OR “herbal medicine” OR “herb” OR “herbs” OR “decoction” OR “tea” OR “infusion” OR “macerate”) AND (“snake venom” OR “snake” OR “snakes” OR “snakebite” OR “snakebites” OR “antivenom” OR “antivenoms” OR “anti-venom” OR “anti-venoms” OR “antivenin” OR “antivenins” OR “anti-venin” OR “anti-venins” OR “antiophidian” OR “antiophidic” OR “snake envenomation” OR “antitoxin” OR “antitoxins” OR “snake antidote” OR “snake antidotes” OR “snake venom neutralization” OR “snake venom inhibition” OR “snake toxins inhibition” OR “snake toxins neutralization” OR “viper” OR “viperidae” OR “crotalinae” OR “viperinae” OR “elapidae” OR “pit-viper” OR “bothrops” OR “jararaca” OR “crotalus” OR “micrurus” OR “lachesis” OR “cobra” OR “naja” OR “bitis” OR “vipera” OR “daboia” OR “trimeresus”).

All abstracts and/or full-text data were considered, without language restriction. Then, the publications covering ethnobotanical and/or pharmacological studies of antiophidic plants were selected and carefully analyzed. With the information gathered in these studies, the actual scenario of the use of plants against snake venom was pointed out. Main botanical families used, main countries where antiophidic plants are reported, and mode of use mostly employed in folk medicine were described. Regarding studies of pharmacological evidence, the snake species that were most studied, which plant species were tested and presented positive results, correlating with those species that also presented record of ethnopharmacological use, were also reported.

The accepted botanical name of each medicinal plant listed was confirmed in at least 2 botanical databases among the following ones: Flora do Brasil (http://www.floradobrasil.jbrj.gov.br/), Tropicos (http://www.tropicos.org/), The Plant List (http://www.theplantlist.org/), and NCBI Taxonomy Browser (https://www.ncbi.nlm.nih.gov/taxonomy). In some cases, where the same species was considered as different ones (different synonyms used) in different papers, the accepted name according to the botanical databases mentioned above was used in the present review, bringing the synonym used in the original work between parenthesis.

3. Medicinal Plants as a Popular Source of Antidotes for Snakebites: Traditional Use

According to the literature search performed, a lot of ethnopharmacological studies showing medicinal plants claimed as antiophidic were found. A summary of these vegetal species can be observed in Table 1.

Table 1
List of medicinal plants used against snakebites.

Along our survey were found 150 botanical families containing plants with reputation against snakebites, among which the most cited ones were the families Fabaceae, Asteraceae, Apocynaceae, Lamiaceae, Rubiaceae, Euphorbiaceae, Araceae, Malvaceae, and Acanthaceae (Figure 1(a)). In a cross-cultural comparison of medicinal floras used against snakebites, Molander et al. [80] identified five countries with a high number of antiophidic plants and representing different cultures, geography, and floristic zones: Brazil, Nicaragua, Nepal, China, and South Africa. From these countries, some “hot” families were identified, which were Apocynaceae, Lamiaceae, Rubiaceae, and Zingiberaceae [80], similar to the present review, except for the Zingiberaceae family which was not so reported in our survey.

Figure 1
“Hot families” with antiophidic potential. Main related botanical families in ethnopharmacological surveys as antiophidic (a) and main botanical families that were evaluated in antiophidic assay (inhibition of local tissue damage) and ...

Medicinal plants with reputation against snakebites are found all over the world, especially in tropical or subtropical regions of Asia, Americas, and Africa (Figure 2). This fact may be associated with richness of flora of these regions, as well as with relative need of complementary therapies to treat snakebites, considering geographical features that could limit the distribution and availability of the antivenoms in these areas.

Figure 2
Distribution of medicinal plants used against snakebite around the world. World map highlighting the countries where antiophidic plants were related in ethnopharmacological surveys (a) and number of vegetal species per continent (b).

As observed in Figure 3(a), leaves and roots are the parts of plants most used in folk medicine. Regarding the mode of use, the most frequent one is the topical application of the vegetal products directly on the place of the bite (Figure 3(b)). This is interesting especially in snake venoms that cause serious local tissue damage, such as Bothrops and Daboia species. Since these snakes produce intense local tissue damage, which has a very rapid onset, a topical treatment could be interesting for a rapid inhibitory action. On the other hand, interestingly, the use of some plant species is made by internal and external routes simultaneously, while for some other species the route of administration could be chosen among internal or external use. However, since in several cases this information is not clear, this differentiation was not considered in data tables. Regarding the mode of preparation, in general, paste and decoction were the most cited forms of use. However, for most of the plants enlisted, the information of mode of preparation was missing or confusing.

Figure 3
Mode of utilization of antiophidic plants reported by folk medicine. Main plant parts used (a) and Venn diagram showing the number of species enlisted having external use, internal use, or both (b).

It is important to emphasize that these plant species, in addition to their use as antiophidic agents, present a series of another popular uses (data not shown) in popular medicine, mainly anti-inflammatory activity. For example, Jatropha gossypiifolia (Euphorbiaceae) has antiophidic, anti-inflammatory, analgesic, antipyretic, healing, and antihemorrhagic uses, among others [81].

4. Antivenom Activities of Extracts of Medicinal Plants against Snake Venom Induced Local Tissue Damage

4.1. General Aspects

Until date, according to our database, only a few numbers (less than 20%) of the species with reputation against snakebites were tested in preclinical assays with different snake venoms, which shows that there is still a great road for the study of antiophidic plants. From these tested plants which have popular use documented in our database, more than a half (almost 60%) showed positive results, which shows that in fact ethnobotany could be a good tool for bioprospecting of plants with antiophidic activity. In addition, the fact that among the tested vegetal species very significative results were obtained strongly suggests the potentiality of these natural products as a future source for development of snake venom inhibitors.

The plant families with most vegetal species showing positive results in antiophidic tests were Fabaceae, Euphorbiaceae, Apocynaceae, Lamiaceae, Asteraceae, Malvaceae, Melastomaceae, and Sapindaceae (Figure 1(b)). Crossing the data of popular use (Figure 1(a)) and of positive activity (Figure 1(b)), we can highlight these families as “hot” ones, that is, families that might be preferred or prioritized in studies searching for antiophidic plants.

Snakes from the genus Naja, Bothrops, and Bitis were the most evaluated ones in these antiophidic assays. However, although Naja and Bitis comprise a large fraction of the studies, virtually most of them are only in vitro studies, dealing with the in vitro enzymatic inhibition of classes of venom toxins relevant to local tissue damage, such as phospholipases A2 (PLA2s), hyaluronidases (SVHs), and proteases. More particularly, the great majority of these studies with Naja and Bitis snakes are part of the work undertaken by Molander et al. [82], aiming to investigate whether plants used in traditional medicine systems would be active against necrosis-inducing enzymes of snake venoms, having tested a total of 226 extracts from 94 plants from the countries of Mali, Democratic Republic of Congo, and South Africa against PLA2, SVHs, and proteases from Bitis arietans and Naja nigricollis (see Tables Tables22 and and4).4). Studies evaluating the inhibitory action of medicinal plants against these enzymes are very relevant, since they are involved in several pathological mechanisms produced by snake venoms; however, in vivo preclinical assays or, even better, clinical assays are essential for giving even stronger evidences of the effectivity of the use of medicinal plants against snakebites. In this scenario, the study of anti-Bothrops plants is more advanced, since quantitatively a higher number of in vivo scientific evidences are found in literature. Going the same way, studies with plants inhibiting local tissue damage of Daboia/Vipera, Lachesis, and Crotalus snakes could be also highlighted. However, studies of antiophidic medicinal plants in humans are very scarce: only one clinical study was found in literature, evaluating the inhibitory properties of a polyherbal formulation against local effects from Chinese cobra bite (see Section 4.9).

Table 2
List of medicinal plants with inhibitory potential against local effects induced by Naja snakes.
Table 4
List of medicinal plants with inhibitory potential against local effects induced by Bitis snakes.

Hereafter, we describe the main plants with inhibitory potential against local tissue damage induced by snake venoms. It is important to emphasize that the focus of this review is plants against local tissue damage, mainly due to severity of these effects (which could cause permanent disabilities in victims) and the poor effectiveness of available antivenoms against them. So, studies with plants against systemic effects induced by snake were not considered; in addition some plants herein described possess inhibitory action upon systemic effects, although not stated here. For example, the vegetal species Jatropha gossypiifolia (Euphorbiaceae), a medicinal plant studied very much by our research group, had showed significative inhibitory action upon hemostatic disorders induced by B. jararaca snake venom [96]. So, the antiophidic potential of this species (as well as some others) lies beyond the capacity of inhibit local tissue damage provoked by B. jararaca venom, although not described in this review.

In addition, it is important to analyze critically some works dealing with antiophidic activity of plant extracts, since some of them have limitations that could reduce, at least partially, the potentiality of these species. The major limitation is that various studies, especially the early ones, make the evaluation of the plants using a preincubation approach, which consists in the previous inactivation of venom by preincubating it with different proportions of the tested extracts. Although scientifically valid and even recommended by WHO for assessing antiophidic antivenoms [97], this preincubation approach makes a scenario unlikely to be possible in the field, where the medicine would be delivered after the snakebite. In fact, a recent study evaluated the inhibitory action of the medicinal plant Bellucia dichotoma (Melastomataceae) against Bothrops atrox snake venom using different protocols: preincubation, pretreatment, and posttreatment [98]. The authors observed that while the extract was greatly active when preincubated, this inhibitory activity was drastically reduced or even lost when the extract was injected independently of venom, simulating traditional use. The authors observed that the extract has great amounts of tannins, which are compounds known to precipitate proteins. So, it was concluded that the “pseudo-inhibition” observed after preincubation may be due to the presence of these compounds, suggesting that the preincubation protocol overestimates inhibitory potential of medicinal plants, and for this reason, this kind of approach must be analyzed with caution for estimation of inhibitory potential of medicinal plants [13, 98]. In this sense, many recent studies have been done using protocols of pre- and/or posttreatment, to ensure the potentiality of antiophidic plants, and for most of them, positive results have been found [96, 98102]. For this reason, studies using preincubation protocol are marked in the tables, for a critical analysis.

Also, it is interesting to note that several of the plants with inhibitory potential against snake venom local toxicities also present other relevant pharmacological activities. This is interesting since it is often discussed in the literature that several antiophidic plants did not neutralize snake venoms per se, but could have antiophidic use once they could relieve some of the symptoms of snake envenoming, especially the local effects. It is related that the presence of tranquilizing, antioxidant, immunostimulating, and/or anti-inflammatory activities in certain plants could be of great interest in the alleviation of snake envenoming symptoms [103, 104]. For example, some studies have shown that anti-inflammatory drugs could inhibit the edematogenic and other snake venom effects related to inflammation, such as necrosis and myotoxicity, induced by Bothrops venoms [105, 106]. In fact, many medicinal plants with antiophidic activity also possess significant anti-inflammatory activity in vivo [83, 96, 107110]. Following the same reasoning, some plants with antioxidant activity also possess significant antiophidic effects [95, 96, 104, 111]. In fact, some authors suggest that molecules with antioxidant and/or anti-inflammatory effects could be interesting along with antivenom therapy, helping to reduce the occurrence of secondary/long term complication due to snakebites [112].

Bacterial infection secondary to snakebites is a common complication in envenomed victims [113, 114]. The main source of bacteria is the oral cavity of snakes, but the microbiota in the different layers of the victim's skin or even microorganisms from victim's clothes could also contribute [115, 116]. Abscess formation is a common complication found in patients bitten by Viperidae snakes, being a risk factor for amputation in these patients, and it may be associated with sepsis [113, 114, 117]. A large number of bacteria, including anaerobic species, aerobic gram-negative rods, and a small proportion of gram-positive cocci could be inoculated with snakebites and have been isolated from the abscesses of bitten patients [113, 114]. Microorganisms such as Staphylococcus, Pseudomonas, Salmonella, Escherichia, Providencia, Proteus, Enterococcus, and Bacillus were already identified in oral cavity of certain snakes [116]. The use of antibiotics following snakebites is often recommended, usually therapeutically than prophylactically, mainly to avoid complications due to infections [114, 118]. In this context, medicinal plants presenting antimicrobial activities, especially against those microorganisms usually detected in snakebite victims' abscesses, could be interesting [115].

Medicinal plants having antimicrobial activities in association with some of the pharmacological properties discussed above (such as anti-inflammatory and antioxidant, e.g.) could be of great value to relieve especially local effects induced by snake venom. In another point of view, it is possible that several related plants in folk medicine as antiophidic agents do not act directly upon venom toxins but indirectly on its symptoms. Anyway, some studies have shown the potentiality of some vegetal species acting in two ways: directly, neutralizing venom toxins, or indirectly, by having some of the pharmacological activities mentioned above. For example, Jatropha gossypiifolia (Euphorbiaceae), a plant species studied very much in our research group, showed significant antiophidic properties, inhibiting biological and enzymatic activities from Bothrops venoms [96, 119], and presented anti-inflammatory, antioxidant, anticoagulant, and antimicrobial properties in preclinical assays [81]. So, plants which possess these biological activities determined in previous studies might be preferred or prioritized in studies searching for antiophidic plants.

The mechanism by which medicinal plants neutralize the toxic venom constituents is still unknown, but many hypotheses have been proposed, such as protein precipitation, enzyme inactivation, proteolytic degradation, metal chelation, antioxidant action, and a combination of these mechanisms [15]. In this context, some improvements in this understanding have been achieved in the last years, through the use of in silico methods (e.g., docking simulations) to analyze the interaction of compounds isolated from plants and certain classes of snake venom toxins such as PLA2 and SVMP [120122].

The use of medicinal plants may present several advantages, such as low cost, being easily available, being stable at room temperature, and possibility of neutralization of a wide range of venom components [15]. In addition, since medicinal plants are an extremely complex mixture, it is possible that there may be a synergistic action of different compounds in plant, acting in distinct targets, inhibiting a broad spectrum of venom toxins [12, 15]. According to literature, interestingly, there are some plants in which the crude extract is more active than the isolated constituents [15], which supports the hypothesis of the synergistic action of plant components.

4.2. Plants Inhibiting Naja Snakes

A summary of active plants against Naja snakes local effects is presented in Table 2. Naja species are commonly called cobras. They typically occur in regions throughout Africa and Southern Asia. The outcomes of venom toxicity include nephro-, neuro-, and cardiotoxicity, respiratory and circulatory collapse, necrosis, hemorrhage, and edema [13]. A great number of the plants showed in this review were tested against Naja species. However, it is important to mention that only a very small number of these plants were assessed in vivo, and so the scientific evidences of antiophidic activities of these species are based on enzymatic in vitro assays, especially against SVHs, a class of toxin particularly relevant in cobras. The study of Molander et al. [82] presented several medicinal plants identified as potent inhibitors of N. nigricollis SVHs, PLA2, and proteases, which could indicate a potential rich source of inhibitors of necrosis induced by these venom, which must be evaluated in vivo later [82]. The same group, in a more recent study [123], investigated the skin permeation, ex vivo inhibition of venom induced tissue destruction, and wound healing potential of African plants used against snakebite, which included the most potent inhibitors identified in the previous work [82]. A total of 30 plant species were tested against Naja nigricollis and Bitis arietans employing in vitro and ex vivo models [123]. However, although plant extracts have showed potential in inhibiting snake venom enzymes, this study showed no effect against cell death and tissue damage.

4.3. Plants Inhibiting Bothrops Snakes

A summary of active plants against Bothrops snakes local effects is presented in Table 3. More than 90% of the snakebites reported every year in Latin America are caused by Bothrops species [8]. Envenomation by Bothrops snakes is characterized by a prominent and complex series of local pathological alterations, which appear rapidly after the bite in the anatomical site where venom is inoculated [168]. In a number of Bothrops bite cases, lack of neutralization of local effects results in permanent sequelae, with significative tissue loss [8]. So, the use of a therapeutic approach with high inhibitory potential and easy access and disponibility to victims, which could neutralize rapidly the onset of these local manifestations, is interesting. Most of the inhibitory studies with Bothrops snakes were performed in Brazil, which could be associated with richness of Brazilian flora as well as the epidemiological aspects of this country. The work performed by De Moura et al. [33] could be highlighted, where these authors performed an ethnopharmacological-guided screening of plants with reputation against snakebite in Santarém, Western Pará, Brazil. Twelve species were evaluated against Bothrops jararaca snake venom induced hemorrhage and some of them presented very significative results, showing, thus, the relevance of traditional knowledge in the survey of antiophidic plants [33].

Table 3
List of medicinal plants with inhibitory potential against local effects induced by Bothrops snakes.

4.4. Plants Inhibiting Bitis Snakes

A summary of active plants against Bitis snakes local effects is presented in Table 4. Snakes belonging to the genus Bitis are implicated in many accidents with humans in Africa. The envenomation by Bitis often results in severe local damage, hypotension, coagulopathy, thrombocytopenia, and spontaneous local bleeding and, in the absence of antivenom therapy, the accident can be fatal. Bitis arietans is one of the three species of snakes of medical importance in Africa and its venom is considered the most toxic venom of the viper group [169]. Regarding the plants with inhibitory action upon Bitis snakes, only one in vivo study of antiophidic activity was found until date. Although many works have been showing the potential of medicinal plants against several snake venoms, only three works were identified evaluating the action of plants against Bitis, from which two are the same screening studies of plants against Naja snake venom discussed before (Section 4.2) [82, 123].

4.5. Plants Inhibiting Daboia/Vipera Snakes

A summary of active plants against Daboia/Vipera snakes local effects is presented in Table 5. The Daboia genus is represented by a single species, named Daboia russelii, also popularly known as Russell's viper. This species is widespread in many parts of Asia and is responsible for large morbimortality due to snakebites in this continent [183, 184]. Russell's viper was formerly classified in Vipera genus and is therefore better known as Vipera russelii, since the new accepted nomenclature (Daboia russelii) is not yet universally followed [184]. For this reason, to avoid confounding, we use the term Daboia/Vipera in some occasions.

Table 5
List of medicinal plants with inhibitory potential against local effects induced by Daboia/Vipera snakes.

In humans, Russell's viper bite causes severe local tissue damage; more frequently the necrosis results in an irreversible loss of tissue and requires amputation of the affected limb [182, 183, 185]. As observed with Bothrops snakes, several studies have showed the inhibitory potential of medicinal plants against local effects of Russell's viper venom, including several preclinical in vivo studies.

4.6. Plants Inhibiting Lachesis Snakes

A summary of active plants against Lachesis snakes local effects is presented in Table 6. Lachesis muta is the longest venomous snake in the Americas and is distributed in the equatorial forests east of the Andes, ranging from eastern Ecuador, Colombia, Peru, northern Bolivia, and eastern and northern Venezuela, to Guyana, French Guyana, Surinam, and northern Brazil [100, 186]. L. muta snakebites are mainly characterized by systemic (generalized bleeding, coagulopathy, renal failure, and shock) and local effects (pain, hemorrhage, edema, and necrosis). In South America, Bothrops species has a higher incidence of accidents than L. muta, but, on the other hand, Lachesis bites led to more severe symptoms and have lethality indexes significantly higher than Bothrops [100, 186, 187]. Thus, the study of medicinal plants against these snakes, too, is of very much relevance. However, only a few studies were detected with plants against Lachesis snakes.

Table 6
List of medicinal plants with inhibitory potential against local effects induced by Lachesis snakes.

4.7. Plants Inhibiting Crotalus Snakes

A summary of active plants against Crotalus snakes local effects is presented in Table 7. Snakes from Crotalus durissus complex, popularly known as rattlesnakes, are dispersed northward into North America and southward into South America. Species of the Crotalus durissus complex pose a serious medical problem in many parts of the America [199]. Crotalic venom is considered highly toxic and more lethal in comparison with that of the genus Bothrops, having three main actions: neurotoxic, myotoxic, and coagulant [200, 201]. The crotalic accident is characterized by local and systemic manifestations, but while the local alterations are only discrete, the systemic manifestations are severe, leading to high chances of death [201]. Probably due to this low local effect in envenomed victims, the inhibition of these effects by plants is, until now, little investigated, especially when compared to other species with characteristic severe local effects.

Table 7
List of medicinal plants with inhibitory potential against local effects induced by Crotalus snakes.

4.8. Plants Inhibiting Other Snakes

Besides the snakes discussed above, some other studies are found with plants inhibiting other snake species, such as those from Echis and Bungarus genus. For other snakes species such as Calloselasma rhodostoma, Philodryas olfersii, and Montivipera xanthina, only isolated studies with a single plant, in each one, were found. These plants are summarized in Table 8. Many reasons may be stated for this lack of studies, such as low level of local effects, incidence restricted to a small region of the world, and usual low efficacy of plant extracts due to possible extremely high toxicity. However, it is important to highlight that the lack of studies does not mean a lower medical relevance of these species. For example, the saw-scaled viper (Echis carinatus) and the common Indian krait (Bungarus caeruleus), along with spectacled cobra (Naja naja) and Russell's viper (Daboia russelii), are included among the referred “Big Four” venomous snakes of India, being responsible for the majority of morbid complications, characterized by persistent and progressive tissue necrosis even after treatment with antivenom [195, 202]. Therefore, future studies with plants aiming at the inhibition of the local effects induced by these snakes are encouraged.

Table 8
List of medicinal plants with inhibitory potential against local effects induced by other snakes.

4.9. Studies in Humans

Along our antiophidic plants database, only one clinical study was found in literature, evaluating the inhibitory properties of a polyherbal formulation, externally applied, against soft-tissue necrosis after Naja atra (Chinese cobra) bite [203]. This polyherbal formulation, known in China as Jidesheng antivenom, is composed of the following ingredients: Ganchan (Succys Bufo), Dijincao (Herba Euphorbiae Humifusae), Chonglou (Rhizoma Paridis Chonglou), and Wugong (Scolopendra). This was a retrospective study performed with 126 patients with skin and soft-tissue necrosis due cobra bite, with the control group being treated externally with 40% glyceride magnesium sulfate (n = 52) and the treatment group performed by application of Jidesheng antivenom externally (n = 74). The authors observed statistically significant differences in maximum local necrotic area of skin and soft tissues, healing time, and skin-grafting rate between the control and treatment groups (P < 0.05), thus indicating that external application of Jidesheng antivenom may help to promote wound healing and reduce the skin-grafting rate in cases of skin and soft-tissue necrosis due to Chinese cobra bite [203]. Considering the composition of the Jidesheng antivenom, the authors discuss that each ingredient in this product may exert antipyretic, antidotal, antiphlogistic, and analgesic effects, according to previous results with each ingredient isolated, which could contribute to the inhibitory effect observed by the formulation [203]. The result obtained in this clinical study is very promising, since it shows that a plant-derived product showed significant results in humans, thus pointing to the potentiality of this kind of product in treatment of snake venom induced local effects. However, only one study is insufficient to ensure the potentiality of medicinal plants against snakebites, with performing more clinical studies, preferentially controlled and randomized ones, to bring more evidences of the viability of the approach for future safe and effective use in humans being necessary. So, more clinical studies, especially ones with those plants highlighted in this review and those presenting good preclinical in vivo evidences of antiophidic efficacy, are highly encouraged.

5. Concluding Remarks

The popular use of vegetal species does not necessarily imply efficacy, but it gives a selected list of medicinal plants that can be primarily studied in pharmacologic assays for possible antiophidic effects, directing future studies in this area. In fact, a great number of these species that have been evaluated against local tissue damage induced by several snake species showed inhibitory potential against hyaluronidase, phospholipase, proteolytic, hemorrhagic, myotoxic, and edematogenic activities, among others. Therefore, considering the limitations of conventional antivenom serotherapy, especially its poor efficacy against local effects, the treatment with medicinal plants may provide a potential adjuvant alternative to treat snakebites, being used to complement the activity and effectiveness of available snake venom therapy. The main potential advantages of antiophidic plants are their low cost, easy access, stability at room temperature, and ability to neutralize a broad spectrum of toxins, including the local tissue damage.

Interestingly, some studies have showed that the crude extracts are more powerful than the individual herbal compounds, which could, at a certain extent, justify the development of herbal products containing these plants instead of medicines containing isolated compounds, which in turn could be more rapidly available in market, after proof of safety, effectiveness, and quality of these products. However, despite the existence of many plants with great potential, no natural antiophidic product is available in market, which points to question of the need for further studies. Only a few numbers of patents regarding herbal products against snakebites were found in literature. Some patents regarding the use of Chinese medicinal plants against snake and bug bites were found. In our research group, two patents were deposited concerning the processes of obtaining extracts, fraction, isolated compounds, and pharmaceutical compositions of some plants studied by our group applied in the treatment of accidents with venomous animals (BR 10 2013 034046 4 A2 and BR 10 2012 026958 9 A2). Thus, the number of patents with antiophidic herbal products is still relatively small. For this reason, we encourage pharmacologists and toxinologists around the world to intensify studies with antiophidic plants, especially prioritizing those with the greatest number of indications in traditional medicine and emphasizing clinical studies with the most active plants in preclinical studies, given that the low number of human studies is one of the major obstacles for the future application of herbal products with antiophidic potential. No less important, toxicological studies are also extremely necessary to ensure the safety of these products.

In conclusion, the data presented in this review provides an updated scenario for and insights into future research aiming at validation of medicinal plants as antiophidic agents and, based on scientific evidences, strengthens the potentiality of medicinal plants and ethnopharmacological knowledge as a tool for design of potent inhibitors and/or herbal medicines against venom toxins.

Acknowledgments

Matheus de Freitas Fernandes-Pedrosa is CNPq fellowship-honored researcher. Juliana Félix-Silva acknowledges CAPES for the Ph.D. scholarship.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

1. Gutiérrez J. M., Burnouf T., Harrison R. A., et al. A call for incorporating social research in the global struggle against snakebite. PLoS Neglected Tropical Diseases. 2015;9(9, article e0003960) doi: 10.1371/journal.pntd.0003960. [PMC free article] [PubMed] [Cross Ref]
2. Kasturiratne A., Wickremasinghe A. R., de Silva N., et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Medicine. 2008;5(11, article e218) doi: 10.1371/journal.pmed.0050218. [PMC free article] [PubMed] [Cross Ref]
3. Gutiérrez J. M., Warrell D. A., Williams D. J., et al. The need for full integration of snakebite envenoming within a global strategy to combat the neglected tropical diseases: the way forward. PLoS Neglected Tropical Diseases. 2013;7(6) doi: 10.1371/journal.pntd.0002162.e2162 [PMC free article] [PubMed] [Cross Ref]
4. Harrison R. A., Hargreaves A., Wagstaff S. C., Faragher B., Lalloo D. G. Snake envenoming: a disease of poverty. PLoS Neglected Tropical Diseases. 2009;3(12, article e569) doi: 10.1371/journal.pntd.0000569. [PMC free article] [PubMed] [Cross Ref]
5. Warrell D. A. Venomous animals. Medicine. 2012;40(3):159–163. doi: 10.1016/j.mpmed.2011.12.001. [Cross Ref]
6. Guimarães C. L. S., Moreira-Dill L. S., Fernandes R. S., et al. Biodiversity as a source of bioactive compounds against snakebites. Current Medicinal Chemistry. 2014;21(25):2952–2979. doi: 10.2174/09298673113206660295. [PubMed] [Cross Ref]
7. Kang T. S., Georgieva D., Genov N., et al. Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis. The FEBS Journal. 2011;278(23):4544–4576. doi: 10.1111/j.1742-4658.2011.08115.x. [PubMed] [Cross Ref]
8. GutiΘrrez J. M., Lomonte B. Local tissue damage induced by Bothrops snake venoms. A review. Memorias do Instituto Butantan. 1989;51(4):211–23.
9. Gutiérrez J. M., León G., Burnouf T. Antivenoms for the treatment of snakebite envenomings: the road ahead. Biologicals. 2011;39(3):129–142. doi: 10.1016/j.biologicals.2011.02.005. [PubMed] [Cross Ref]
10. León G., Herrera M., Segura Á., Villalta M., Vargas M., Gutiérrez J. M. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon. 2013;76:63–76. doi: 10.1016/j.toxicon.2013.09.010. [PubMed] [Cross Ref]
11. Mors W. B., do Nascimento M. C., Parente J. P., da Silva M. H., Melo P. A., Suarez-Kurtz G. Neutralization of lethal and myotoxic activities of south american rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae) Toxicon. 1989;27(9):1003–1009. doi: 10.1016/0041-0101(89)90151-7. [PubMed] [Cross Ref]
12. Santhosh M. S., Hemshekhar M., Sunitha K., et al. Snake venom induced local toxicities: plant secondary metabolites as an auxiliary therapy. Mini-Reviews in Medicinal Chemistry. 2013;13(1):106–123. doi: 10.2174/138955713804484730. [PubMed] [Cross Ref]
13. Shabbir A., Shahzad M., Masci P., Gobe G. C. Protective activity of medicinal plants and their isolated compounds against the toxic effects from the venom of Naja (cobra) species. Journal of Ethnopharmacology. 2014;157:222–227. doi: 10.1016/j.jep.2014.09.039. [PubMed] [Cross Ref]
14. Dey A., de J. N. Phytopharmacology of antiophidian botanicals: A review. International Journal of Pharmacology. 2012;8(2):62–79. doi: 10.3923/ijp.2012.62.79. [Cross Ref]
15. Gomes A., Das R., Sarkhel S., et al. Herbs and herbal constituents active against snake bite. Indian Journal of Experimental Biology. 2010;48(9):865–878. [PubMed]
16. Sulochana A., Raveendran D., Krishnamma A., Oommen O. Ethnomedicinal plants used for snake envenomation by folk traditional practitioners from Kallar forest region of South Western Ghats, Kerala, India. Journal of Intercultural Ethnopharmacology. 2015;4(1):p. 47. doi: 10.5455/jice.20141010122750. [PMC free article] [PubMed] [Cross Ref]
17. Butt M. A., Ahmad M., Fatima A., et al. Ethnomedicinal uses of plants for the treatment of snake and scorpion bite in Northern Pakistan. Journal of Ethnopharmacology. 2015;168:164–181. doi: 10.1016/j.jep.2015.03.045. [PubMed] [Cross Ref]
18. Dharmadasa R. M., Akalanka G. C., Muthukumarana P. R. M., Wijesekara R. G. S. Ethnopharmacological survey on medicinal plants used in snakebite treatments in Western and Sabaragamuwa provinces in Sri Lanka. Journal of Ethnopharmacology. 2016;179:110–127. doi: 10.1016/j.jep.2015.12.041. [PubMed] [Cross Ref]
19. Kala C. P. Herbal treatment for snakebites in Uttarakhand state of India. Indian Journal of Natural Products and Resources. 2015;6(1):56–61.
20. Samy R. P., Thwin M. M., Gopalakrishnakone P., Ignacimuthu S. Ethnobotanical survey of folk plants for the treatment of snakebites in Southern part of Tamilnadu, India. Journal of Ethnopharmacology. 2008;115(2):302–312. doi: 10.1016/j.jep.2007.10.006. [PubMed] [Cross Ref]
21. Rajadurai M., Vidhya V. G., Ramya M., Bhaskar A. Ethno-medicinal plants used by the traditional healers of pachamalai hills, Tamilnadu, India. Studies on Ethno-Medicine. 2009;3(1):39–41.
22. Sarkhel S. Ethnobotanical survey of folklore plants used in treatment of snakebite in Paschim Medinipur district, West Bengal. Asian Pacific Journal of Tropical Biomedicine. 2014;4(5):416–420. doi: 10.12980/APJTB.4.2014C1120. [PMC free article] [PubMed] [Cross Ref]
23. Penchalapratap G., Sudarsanam G., Pushpan R., Prasad G. P. Herbal remedies for snake bites in ethnic practices of Chittoor District, Andhra Pradesh. Ancient Science of Life. 2010;29(4):13–16. [PMC free article] [PubMed]
24. Singh A. K., Raghubanshi A. S., Singh J. S. Medical ethnobotany of the tribals of Sonaghati of Sonbhadra district, Uttar Pradesh, India. Journal of Ethnopharmacology. 2002;81(1):31–41. doi: 10.1016/S0378-8741(02)00028-4. [PubMed] [Cross Ref]
25. Kadel C., Jain A. K. Folklore claims on snakebite among some tribal communities of Central India. Indian Journal of Traditional Knowledge. 2008;7(2):296–299.
26. Yesodharan K., Sujana K. A. Ethnomedicinal knowledge among Malamalasar tribe of Parambikulam wildlife sanctuary. Indian Journal of Traditional Knowledge. 2007;6(3):481–85.
27. Coe F. G., Anderson G. J. Snakebite ethnopharmacopoeia of eastern Nicaragua. Journal of Ethnopharmacology. 2005;96(1-2):303–323. doi: 10.1016/j.jep.2004.09.026. [PubMed] [Cross Ref]
28. Prabu M., Kumuthakalavalli R. Folk remedies of medicinal plants for snake bites, scorpion stings and dog bites in Eastern Ghats of Kolli Hills, Tamil Nadu, India. International Journal of Research in Ayurveda and Pharmacy. 2012;3(5):696–700. doi: 10.7897/2277-4343.03523. [Cross Ref]
29. Sanz-Biset J., Campos-de-la-Cruz J., Epiquién-Rivera M. A., Cañigueral S. A first survey on the medicinal plants of the Chazuta valley (Peruvian Amazon) Journal of Ethnopharmacology. 2009;122(2):333–362. doi: 10.1016/j.jep.2008.12.009. [PubMed] [Cross Ref]
30. Hasan M. N., Azam M. N. K., Ahmed M. N., Hirashima A. A randomized ethnomedicinal survey of snakebite treatment in southwestern parts of Bangladesh. Journal of Traditional and Complementary Medicine. 2015;6(4):337–342. doi: 10.1016/j.jtcme.2015.03.007. [PMC free article] [PubMed] [Cross Ref]
31. Owuor B. O., Kisangau D. P. Kenyan medicinal plants used as antivenin: a comparison of plant usage. Journal of Ethnobiology and Ethnomedicine. 2006;2(1, article 7) doi: 10.1186/1746-4269-2-7. [PMC free article] [PubMed] [Cross Ref]
32. Kadir M. F., Karmoker J. R., Alam M. R., Jahan S. R., Mahbub S., Mia M. M. K. Ethnopharmacological survey of medicinal plants used by traditional healers and indigenous people in Chittagong Hill Tracts, Bangladesh, for the treatment of snakebite. Evidence-Based Complementary and Alternative Medicine. 2015;2015:23. doi: 10.1155/2015/871675.871675 [PMC free article] [PubMed] [Cross Ref]
33. De Moura V. M., Freitas De Sousa L. A., Cristina Dos-Santos M., et al. Plants used to treat snakebites in Santarém, western Pará, Brazil: an assessment of their effectiveness in inhibiting hemorrhagic activity induced by Bothrops jararaca venom. Journal of Ethnopharmacology. 2015;161:224–232. doi: 10.1016/j.jep.2014.12.020. [PubMed] [Cross Ref]
34. Vásquez J., Alarcón J. C., Jiménez S. L., et al. Main plants used in traditional medicine for the treatment of snake bites n the regions of the department of Antioquia, Colombia. Journal of Ethnopharmacology. 2015;170:158–166. doi: 10.1016/j.jep.2015.04.059. [PubMed] [Cross Ref]
35. Otero R., Fonnegra R., Jiménez S. L., et al. Snakebites and ethnobotany in the northwest region of Colombia. Part I: traditional use of plants. Journal of Ethnopharmacology. 2000;71(3):493–504. doi: 10.1016/S0378-8741(00)00243-9. [PubMed] [Cross Ref]
36. Rahmatullah M., Hasan A., Parvin W., et al. Medicinal plants and formulations used by the Soren clan of the Santal tribe in Rajshahi District, Bangladesh for treatment of various ailments. African Journal of Traditional, Complementary and Alternative Medicines. 2012;9(3):350–359. doi: 10.4314/ajtcam.v9i3.8. [PMC free article] [PubMed] [Cross Ref]
37. Rigat M., Vallès J., Dambrosio U., Gras A., Iglésias J., Garnatje T. Plants with topical uses in the Ripollès district (Pyrenees, Catalonia, Iberian Peninsula): Ethnobotanical survey and pharmacological validation in the literature. Journal of Ethnopharmacology. 2015;164:162–179. doi: 10.1016/j.jep.2015.01.055. [PubMed] [Cross Ref]
38. Jain A., Katewa S. S., Sharma S. K., Galav P., Jain V. Snakelore and indigenous snakebite remedies practiced by some tribals of Rajasthan. Indian Journal of Traditional Knowledge. 2011;10(2):258–268.
39. Shukla A. N., Srinivastan S., Rawat A. K. S. An ethnobotanical study of medicinal plants of Rewa district, Madhya Pradesh. Indian Journal of Traditional Knowledge. 2010;9(1):191–202.
40. Panghal M., Arya V., Yadav S., Kumar S., Yadav J. P. Indigenous knowledge of medicinal plants used by Saperas community of Khetawas, Jhajjar District, Haryana, India. Journal of Ethnobiology and Ethnomedicine. 2010;6, article 4 doi: 10.1186/1746-4269-6-4. [PMC free article] [PubMed] [Cross Ref]
41. Khan A. V., Ahmed Q. U., Khan M. W., Khan A. A. Herbal cure for poisons and poisonous bites from Western Uttar Pradesh, India. Asian Pacific Journal of Tropical Disease. 2014;4(1):S116–S120. doi: 10.1016/S2222-1808(14)60425-4. [Cross Ref]
42. Sikdar M., Dutta U. Traditional phytotherapy among the Nath people of Assam. Studies on Ethno-Medicine. 2008;2(1):39–45.
43. Khan M. A., Khan S. A., Quresh M. A., et al. Ethnobotany of some useful plants of poonch valley azad kashmir. Journal of Medicinal Plant Research. 2011;5(26):6140–6151. doi: 10.5897/JMPR11.045. [Cross Ref]
44. Vásquez J., Jiménez S. L., Gómez I. C., et al. Snakebites and ethnobotany in the eastern region of Antioquia, Colombia—the traditional use of plants. Journal of Ethnopharmacology. 2013;146(2):449–455. doi: 10.1016/j.jep.2012.12.043. [PubMed] [Cross Ref]
45. Sivasankari B., Anandharaj M., Gunasekaran P. An ethnobotanical study of indigenous knowledge on medicinal plants used by the village peoples of Thoppampatti, Dindigul district, Tamilnadu, India. Journal of Ethnopharmacology. 2014;153(2):408–423. doi: 10.1016/j.jep.2014.02.040. [PubMed] [Cross Ref]
46. Mebs D. Notes on the traditional use of plants to treat snake bite in northern Papua New Guinea. Toxicon. 2000;38(2):299–302. doi: 10.1016/S0041-0101(99)00148-8. [PubMed] [Cross Ref]
47. Agra M. D. F., Silva K. N., Basílio I. J. L. D., De Freitas P. F., Barbosa-Filho J. M. Survey of medicinal plants used in the region Northeast of Brazil. Brazilian Journal of Pharmacognosy. 2008;18(3):472–508. doi: 10.1590/S0102-695X2008000300023. [Cross Ref]
48. Ritter R. A., Monteiro M. V. B., Monteiro F. O. B., et al. Ethnoveterinary knowledge and practices at Colares island, Pará state, eastern Amazon, Brazil. Journal of Ethnopharmacology. 2012;144(2):346–352. doi: 10.1016/j.jep.2012.09.018. [PubMed] [Cross Ref]
49. Murthy K. S., Sharma P. C., Kishore P. Tribal remedies for snakebite from Orissa. Ancient Science of Life. 1986;6(2):122–123. [PMC free article] [PubMed]
50. Di Stasi L. C., Hiruma-Lima C. A. Plantas medicinais na Amazônia e na Mata Atlântica. 2nd. São Paulo, Brazil: UNESP; 2002.
51. Belayneh A., Bussa N. F. Ethnomedicinal plants used to treat human ailments in the prehistoric place of Harla and Dengego valleys, eastern Ethiopia. Journal of Ethnobiology and Ethnomedicine. 2014;10, article 18 doi: 10.1186/1746-4269-10-18. [PMC free article] [PubMed] [Cross Ref]
52. Ayyanar M., Ignacimuthu S. Ethnobotanical survey of medicinal plants commonly used by Kani tribals in Tirunelveli hills of Western Ghats, India. Journal of Ethnopharmacology. 2011;134(3):851–864. doi: 10.1016/j.jep.2011.01.029. [PubMed] [Cross Ref]
53. Haq F., Ahmad H., Alam M. Traditional uses of medicinal plants of Nandiar Khuwarr catchment (District Battagram), Pakistan. Journal of Medicinal Plants Research. 2011;5(1):39–48.
54. Cheikhyoussef A., Shapi M., Matengu K., Ashekele H. M. Ethnobotanical study of indigenous knowledge on medicinal plant use by traditional healers in Oshikoto region, Namibia. Journal of Ethnobiology and Ethnomedicine. 2011;7, article 10 doi: 10.1186/1746-4269-7-10. [PMC free article] [PubMed] [Cross Ref]
55. Jain A., Katewa S. S., Galav P. K., Sharma P. Medicinal plant diversity of Sitamata wildlife sanctuary, Rajasthan, India. Journal of Ethnopharmacology. 2005;102(2):143–157. doi: 10.1016/j.jep.2005.05.047. [PubMed] [Cross Ref]
56. Dutt H. C., Bhagat N., Pandita S. Oral traditional knowledge on medicinal plants in jeopardy among Gaddi shepherds in hills of northwestern Himalaya, J&K, India. Journal of Ethnopharmacology. 2015;168:337–348. doi: 10.1016/j.jep.2015.03.076. [PubMed] [Cross Ref]
57. Odonne G., Valadeau C., Alban-Castillo J., Stien D., Sauvain M., Bourdy G. Medical ethnobotany of the Chayahuita of the Paranapura basin (Peruvian Amazon) Journal of Ethnopharmacology. 2013;146(1):127–153. doi: 10.1016/j.jep.2012.12.014. [PubMed] [Cross Ref]
58. Jankovic M. Communication and shared information. Philosophical Studies. An International Journal for Philosophy in the Analytic Tradition. 2014;169(3):489–508. doi: 10.1007/s11098-013-0205-8. [Cross Ref]
59. Hernandez M. R., Avila-Bello C. H., Morales-Mavil J. E. Etnobotánica y ecología de plantas utilizadas por tres curanderos contra la mordedura de serpiente en la región de Acayucan, Veracruz, México. Boletin de la Sociedad Botanica de Mexico. 2007;81:89–100.
60. Rahmatullah M., Ferdausi D., Mollik M. A. H., Jahan R., Chowdhury M. H., Haque W. M. A survey of medicinal plants used by Kavirajes of Chalna area, Khulna district, Bangladesh. African Journal of Traditional, Complementary and Alternative Medicines. 2010;7(2):91–97. [PMC free article] [PubMed]
61. Giovannini P. Medicinal plants of the Achuar (Jivaro) of Amazonian Ecuador: ethnobotanical survey and comparison with other Amazonian pharmacopoeias. Journal of Ethnopharmacology. 2015;164:78–88. doi: 10.1016/j.jep.2015.01.038. [PubMed] [Cross Ref]
62. Karuppaiya P., Tsay H. S. Therapeutic values, chemical constituents and toxicity of Taiwanese Dysosma pleiantha: a review. Toxicology Letters. 2015;236(2):90–97. doi: 10.1016/j.toxlet.2015.05.004. [PubMed] [Cross Ref]
63. Kshirsagar R. D., Singh N. P. Some less known ethnomedicinal uses from Mysore and Coorg districts, Karnataka state, India. Journal of Ethnopharmacology. 2001;75(2-3):231–238. doi: 10.1016/S0378-8741(01)00199-4. [PubMed] [Cross Ref]
64. De Albuquerque U. P., Andrade L. D. H. C. Uso de recursos vegetais da caatinga: O caso do agreste do Estado de Pernambuco (Nordeste do Brasil) Interciencia. 2002;27(7):336–346.
65. Cheikhyoussef A., Embashu W. Ethnobotanical knowledge on indigenous fruits in Ohangwena and Oshikoto regions in Northern Namibia. Journal of Ethnobiology and Ethnomedicine. 2013;9(1, article 34) doi: 10.1186/1746-4269-9-34. [PMC free article] [PubMed] [Cross Ref]
66. Shah A., Bharati K. A., Ahmad J., Sharma M. New ethnomedicinal claims from Gujjar and Bakerwals tribes of Rajouri and Poonch districts of Jammu and Kashmir, India. Journal of Ethnopharmacology. 2015;166:119–128. doi: 10.1016/j.jep.2015.01.056. [PubMed] [Cross Ref]
67. Ong H. C., Nordiana M. Malay ethno-medico botany in Machang, Kelantan, Malaysia. Fitoterapia. 1999;70(5):502–513. doi: 10.1016/S0367-326X(99)00077-5. [Cross Ref]
68. Seebaluck R., Gurib-Fakim A., Mahomoodally F. Medicinal plants from the genus Acalypha (Euphorbiaceae): a review of their ethnopharmacology and phytochemistry. Journal of Ethnopharmacology. 2015;159:137–157. doi: 10.1016/j.jep.2014.10.040. [PubMed] [Cross Ref]
69. Sharma P., Devi U. Ethnobotanical uses of biofencing plants in Himachal Pradesh, Northwest Himalaya. Pakistan Journal of Biological Sciences. 2013;16(24):1957–1963. doi: 10.3923/pjbs.2013.1957.1963. [PubMed] [Cross Ref]
70. Coelho-Ferreira M. Medicinal knowledge and plant utilization in an Amazonian coastal community of Marudá, Pará State (Brazil) Journal of Ethnopharmacology. 2009;126(1):159–175. doi: 10.1016/j.jep.2009.07.016. [PubMed] [Cross Ref]
71. Oliveira F. C. S., Barros R. F. M., Moita Neto J. M. Medicinal plants used in rural communities from Oeiras Municipality, in the semi-arid region of Piauí State (PI), Brazil. Revista Brasileira de Plantas Medicinais. 2010;12(3):282–301. doi: 10.1590/S1516-05722010000300006. [Cross Ref]
72. Crepaldi C. G., Campos J. L. A., Albuquerque U. P., Sales M. F. Richness and ethnobotany of the family Euphorbiaceae in a tropical semiarid landscape of Northeastern Brazil. South African Journal of Botany. 2016;102:157–165. doi: 10.1016/j.sajb.2015.06.010. [Cross Ref]
73. Murugesan M., Balasubramaniam V., Arthi H. Ethno medical knowledge of plants used by Irula Tribes, Chengal Combai, the Nilgiris, Tamilnadu. Ancient Science of Life. 2005;24(4):179–82. [PMC free article] [PubMed]
74. Nsuala B. N., Enslin G., Viljoen A. “Wild cannabis”: a review of the traditional use and phytochemistry of Leonotis leonurus. Journal of Ethnopharmacology. 2015;174:520–539. doi: 10.1016/j.jep.2015.08.013. [PubMed] [Cross Ref]
75. Swamy M. K., Sinniah U. R. A Comprehensive review on the phytochemical constituents and pharmacological activities of Pogostemon cablin Benth.: an Aromatic Medicinal Plant of Industrial Importance. Molecules. 2015;20(5):8521–8547. doi: 10.3390/molecules20058521. [PubMed] [Cross Ref]
76. Gakuya D. W., Itonga S. M., Mbaria J. M., Muthee J. K., Musau J. K. Ethnobotanical survey of biopesticides and other medicinal plants traditionally used in Meru central district of Kenya. Journal of Ethnopharmacology. 2013;145(2):547–553. doi: 10.1016/j.jep.2012.11.028. [PubMed] [Cross Ref]
77. Hazarika T. K., Lalramchuana, Nautiyal B. P. Studies on wild edible fruits of Mizoram, India used as ethno-medicine. Genetic Resources and Crop Evolution. 2012;59(8):1767–1776. doi: 10.1007/s10722-012-9799-5. [Cross Ref]
78. Gallardo-Casas C. A., Guevara-Balcázar G., Morales-Ramos E., et al. Ethnobotanic study of Randia aculeata (Rubiaceae) in Jamapa, Veracruz, Mexico, and its anti-snake venom effects on mouse tissue. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2012;18(3):287–294. doi: 10.1590/S1678-91992012000300006. [Cross Ref]
79. Xia L., Guo Q., Tu P., Chai X. The genus Casearia: a phytochemical and pharmacological overview. Phytochemistry Reviews. 2014:1–37. doi: 10.1007/s11101-014-9336-6. [PubMed] [Cross Ref]
80. Molander M., Saslis-Lagoudakis C. H., Jäger A. K., Rønsted N. Cross-cultural comparison of medicinal floras used against snakebites. Journal of Ethnopharmacology. 2012;139(3):863–872. doi: 10.1016/j.jep.2011.12.032. [PubMed] [Cross Ref]
81. Félix-Silva J., Giordani R. B., Silva-Jr A. A. D., Zucolotto S. M., Fernandes-Pedrosa M. D. F. Jatropha gossypiifolia L. (Euphorbiaceae): a review of traditional uses, phytochemistry, pharmacology, and toxicology of this medicinal plant. Evidence-Based Complementary and Alternative Medicine. 2014;2014:32. doi: 10.1155/2014/369204.369204 [PMC free article] [PubMed] [Cross Ref]
82. Molander M., Nielsen L., Søgaard S., et al. Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa. Journal of Ethnopharmacology. 2014;157:171–180. doi: 10.1016/j.jep.2014.09.027. [PubMed] [Cross Ref]
83. Thangavel N., Gupta J. K. Anti-inflammatory and anti-snake venom activity of Andrographis stenophylla leaf. Asian Journal of Chemistry. 2007;19(2):1307–1312.
84. Asad M. H. H. B., Razi M. T., Durr-e-Sabih, et al. Anti-venom potential of Pakistani medicinal plants: inhibition of anticoagulation activity of Naja naja karachiensis toxin. Current Science. 2013;105(10):1419–1424.
85. Sakthivel G., Dey A., Nongalleima K., et al. In vitro and in vivo evaluation of polyherbal formulation against Russell's viper and cobra venom and screening of bioactive components by docking studies. Evidence-Based Complementary and Alternative Medicine. 2013;2013:12. doi: 10.1155/2013/781216.781216 [PMC free article] [PubMed] [Cross Ref]
86. Soni P., Bodakhe S. H. Antivenom potential of ethanolic extract of Cordia macleodii bark against Naja venom. Asian Pacific Journal of Tropical Biomedicine. 2014;4:S449–S454. doi: 10.12980/APJTB.4.2014C1048. [PMC free article] [PubMed] [Cross Ref]
87. Ibrahim M. A., Aliyu A. B., Abusufiyanu A., Bashir M., Sallau A. B. Inhibition of naja nigricolis (Reinhardt) venom protease activity by Luffa egyptiaca (Mill) and Nicotiana rustica (Linn) extracts. Indian Journal of Experimental Biology. 2011;49(7):552–554. [PubMed]
88. Gopi K., Renu K., Sannanaik Vishwanath B., Jayaraman G. Protective effect of Euphorbia hirta and its components against snake venom induced lethality. Journal of Ethnopharmacology. 2015;165:180–190. doi: 10.1016/j.jep.2015.02.044. [PubMed] [Cross Ref]
89. Rathnakar Reddi K. V. N., Rajesh S. S., Narendra K., et al. In vitro anti-venom potential of various Jatropha extracts on neutralizing cytotoxic effect induced by phospholipase A2 of crude venom from Indian cobra (Naja naja) Bangladesh Journal of Pharmacology. 2014;9(1):22–28. doi: 10.3329/bjp.v9i1.17410. [Cross Ref]
90. Mahanta M., Mukherjee A. K. Neutralisation of lethality, myotoxicity and toxic enzymes of Naja kaouthia venom by Mimosa pudica root extracts. Journal of Ethnopharmacology. 2001;75(1):55–60. doi: 10.1016/S0378-8741(00)00373-1. [PubMed] [Cross Ref]
91. Girish K. S., Mohanakumari H. P., Nagaraju S., Vishwanath B. S., Kemparaju K. Hyaluronidase and protease activities from Indian snake venoms: Neutralization by Mimosa pudica root extract. Fitoterapia. 2004;75(3-4):378–380. doi: 10.1016/j.fitote.2004.01.006. [PubMed] [Cross Ref]
92. Meenatchisundaram S., Priyagrace S., Vijayaraghavan R., Velmurugan A., Parameswari G., Michael A. Antitoxin activity of Mimosa pudica root extracts against Naja naja and Bangarus caerulus venoms. Bangladesh Journal of Pharmacology. 2009;4(2):105–109. doi: 10.3329/bjp.v4i2.2276. [Cross Ref]
93. Asuzu I. U., Harvey A. L. The antisnake venom activities of Parkia biglobosa (Mimosaceae) stem bark extract. Toxicon. 2003;42(7):763–768. doi: 10.1016/j.toxicon.2003.10.004. [PubMed] [Cross Ref]
94. Gopi K., Renu K., Jayaraman G. Inhibition of Naja naja venom enzymes by the methanolic extract of Leucas aspera and its chemical profile by GC-MS. Toxicology Reports. 2014;1:667–673. doi: 10.1016/j.toxrep.2014.08.012. [Cross Ref]
95. Chatterjee I., Chakravarty A. K., Gomes A. Antisnake venom activity of ethanolic seed extract of Strychnos nux vomica Linn. Indian Journal of Experimental Biology. 2004;42(5):468–475. [PubMed]
96. Félix-Silva J., Souza T., Menezes Y. A. S., et al. Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom. PLoS ONE. 2014;9(8) doi: 10.1371/journal.pone.0104952.e104952 [PMC free article] [PubMed] [Cross Ref]
97. WHO. Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. Geneva, Switzerland: WHO Press; 2010.
98. Mourão De Moura V., Serra Bezerra A. N., Veras Mourão R. H., et al. A comparison of the ability of Bellucia dichotoma Cogn. (Melastomataceae) extract to inhibit the local effects of Bothrops atrox venom when pre-incubated and when used according to traditional methods. Toxicon. 2014;85:59–68. doi: 10.1016/j.toxicon.2014.04.009. [PubMed] [Cross Ref]
99. Fernandes F. F. A., Tomaz M. A., El-Kik C. Z., et al. Counteraction of Bothrops snake venoms by Combretum leprosum root extract and arjunolic acid. Journal of Ethnopharmacology. 2014;155(1):552–562. doi: 10.1016/j.jep.2014.05.056. [PubMed] [Cross Ref]
100. De Oliveira E. C., Fernandes C. P., Sanchez E. F., Rocha L., Fuly A. L. Inhibitory effect of plant Manilkara subsericea against biological activities of Lachesis muta snake venom. BioMed Research International. 2014;2014 doi: 10.1155/2014/408068.408068 [PMC free article] [PubMed] [Cross Ref]
101. Saturnino-Oliveira J., Santos D. D. C., Guimarães A. G., et al. Abarema cochliacarpos extract decreases the inflammatory process and skeletal muscle injury induced by bothrops leucurus venom. BioMed Research International. 2014;2014:9. doi: 10.1155/2014/820761.820761 [PMC free article] [PubMed] [Cross Ref]
102. Strauch M. A., Tomaz M. A., Monteiro-Machado M., et al. Antiophidic activity of the extract of the Amazon plant Humirianthera ampla and constituents. Journal of Ethnopharmacology. 2013;145(1):50–58. doi: 10.1016/j.jep.2012.10.033. [PubMed] [Cross Ref]
103. Houghton P. J., Osibogun I. M. Flowering plants used against snakebite. Journal of Ethnopharmacology. 1993;39(1):1–29. doi: 10.1016/0378-8741(93)90047-9. [PubMed] [Cross Ref]
104. Shenoy P. A., Nipate S. S., Sonpetkar J. M., Salvi N. C., Waghmare A. B., Chaudhari P. D. Anti-snake venom activities of ethanolic extract of fruits of Piper longum L. (Piperaceae) against Russell's viper venom: characterization of piperine as active principle. Journal of Ethnopharmacology. 2013;147(2):373–382. doi: 10.1016/j.jep.2013.03.022. [PubMed] [Cross Ref]
105. Araújo S. D., de Souza A., Nunes F. P. B., Gonçalves L. R. C. Effect of dexamethasone associated with serum therapy on treatment of Bothrops jararaca venom-induced paw edema in mice. Inflammation Research. 2007;56(10):409–413. doi: 10.1007/s00011-007-7054-x. [PubMed] [Cross Ref]
106. Patrão-Neto F. C., Tomaz M. A., Strauch M. A., et al. Dexamethasone antagonizes the in vivo myotoxic and inflammatory effects of Bothrops venoms. Toxicon. 2013;69:55–64. doi: 10.1016/j.toxicon.2013.01.023. [PubMed] [Cross Ref]
107. Gómez-Betancur I., Benjumea D., Patiño A., Jiménez N., Osorio E. Inhibition of the toxic effects of Bothrops asper venom by pinostrobin, a flavanone isolated from Renealmia alpinia (Rottb.) MAAS. Journal of Ethnopharmacology. 2014;155(3):1609–1615. doi: 10.1016/j.jep.2014.08.002. [PubMed] [Cross Ref]
108. Magalhães A., Santos G. B. D., Verdam M. C. D. S., et al. Inhibition of the inflammatory and coagulant action of Bothrops atrox venom by the plant species Marsypianthes chamaedrys. Journal of Ethnopharmacology. 2011;134(1):82–88. doi: 10.1016/j.jep.2010.11.062. [PubMed] [Cross Ref]
109. Pereira I. C., Barbosa A. M., Salvador M. J., et al. Anti-inflammatory activity of Blutaparon portulacoides ethanolic extract against the inflammatory reaction induced by Bothrops jararacussu venom and isolated myotoxins BthTX-I and II. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2009;15(3):527–545. doi: 10.1590/S1678-91992009000300013. [Cross Ref]
110. Reis F. P., Senna Bonfa I. M., Cavalcante R. B., et al. Tabebuia aurea decreases inflammatory, myotoxic and hemorrhagic activities induced by the venom of Bothrops neuwiedi. Journal of Ethnopharmacology. 2014:352–357. doi: 10.1016/j.jep.2014.10.045. [PubMed] [Cross Ref]
111. Pereañez J. A., Lobo-Echeverri T., Rojano B., et al. Correlation of the inhibitory activity of phospholipase A2 snake venom and the antioxidant activity of Colombian plant extracts. Brazilian Journal of Pharmacognosy. 2010;20(6):910–916. doi: 10.1590/S0102-695X2010005000030. [Cross Ref]
112. Sunitha K., Hemshekhar M., Thushara R. M., et al. Inflammation and oxidative stress in viper bite: an insight within and beyond. Toxicon. 2015;98:89–97. doi: 10.1016/j.toxicon.2015.02.014. [PubMed] [Cross Ref]
113. Saravia-Otten P., Gutiérrez J. M., Arvidson S., Thelestam M., Flock J.-I. Increased infectivity of Staphylococcus aureus in an experimental model of snake venom-induced tissue damage. Journal of Infectious Diseases. 2007;196(5):748–754. doi: 10.1086/520537. [PubMed] [Cross Ref]
114. Jorge M. T., Ribeiro L. A. Infections in the bite site after envenoming by snakes of the Bothrops genus. Journal of Venomous Animals and Toxins. 1997;3(2):264–272. doi: 10.1590/S0104-79301997000200002. [Cross Ref]
115. Silva T. P. D., Moura V. M. D., Souza M. C. S. D., et al. Connarus favosus Planch.: An inhibitor of the hemorrhagic activity of Bothrops atrox venom and a potential antioxidant and antibacterial agent. Journal of Ethnopharmacology. 2016;183:166–175. doi: 10.1016/j.jep.2016.02.043. [PubMed] [Cross Ref]
116. Dehghani R., Sharif M. R., Moniri R., Sharif A., Kashani H. H. The identification of bacterial flora in oral cavity of snakes. Comparative Clinical Pathology. 2016;25(2):279–283. doi: 10.1007/s00580-015-2178-9. [Cross Ref]
117. Hearn P., Miliya T., Hor S., Sar V., Turner P. Necrotizing fasciitis complicating snakebite in Cambodia. IDCases. 2015;2(3, article 70):86–87. doi: 10.1016/j.idcr.2015.09.001. [PMC free article] [PubMed] [Cross Ref]
118. Palappallil D. S. Pattern of use of antibiotics following snake bite in a tertiary care hospital. Journal of Clinical and Diagnostic Research. 2015;9(8):OC05–OC09. doi: 10.7860/JCDR/2015/14753.6322. [PMC free article] [PubMed] [Cross Ref]
119. Félix-Silva J., Gomes J. A., Xavier-Santos J. B., et al. Inhibition of local effects induced by Bothrops erythromelas snake venom: assessment of the effectiveness of Brazilian polyvalent bothropic antivenom and aqueous leaf extract of Jatropha gossypiifolia. Toxicon. 2017;125:74–83. doi: 10.1016/j.toxicon.2016.11.260. [PubMed] [Cross Ref]
120. Fernandes C. A. H., Cardoso F. F., Cavalcante W. G. L., et al. Structural basis for the inhibition of a phospholipase A2-like toxin by caffeic and aristolochic acids. PLoS ONE. 2015;10(7) doi: 10.1371/journal.pone.0133370.e0133370 [PMC free article] [PubMed] [Cross Ref]
121. Srinivasa V., Sundaram M. S., Anusha S., et al. Novel apigenin based small molecule that targets snake venom metalloproteases. PLoS ONE. 2014;9(9) doi: 10.1371/journal.pone.0106364.e106364 [PMC free article] [PubMed] [Cross Ref]
122. Pereañez J. A., Patiño A. C., Núñez V., Osorio E. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2. Chemico-Biological Interactions. 2014;220:94–101. doi: 10.1016/j.cbi.2014.06.015. [PubMed] [Cross Ref]
123. Molander M., Staerk D., Mørck Nielsen H., et al. Investigation of skin permeation, ex vivo inhibition of venom-induced tissue destruction, and wound healing of African plants used against snakebites. Journal of Ethnopharmacology. 2015;165:1–8. doi: 10.1016/j.jep.2015.02.014. [PubMed] [Cross Ref]
124. Otero R., Núñez V., Barona J., et al. Snakebites and ethnobotany in the northwest region of Colombia—Part III: Neutralization of the haemorrhagic effect of Bothrops atrox venom. Journal of Ethnopharmacology. 2000;73(1-2):233–241. doi: 10.1016/S0378-8741(00)00321-4. [PubMed] [Cross Ref]
125. Biondo R., Pereira A. M. S., Marcussi S., Pereira P. S., França S. C., Soares A. M. Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract. Biochimie. 2003;85(10):1017–1025. doi: 10.1016/S0300-9084(03)00138-X. [PubMed] [Cross Ref]
126. Veronese E. L. G., Esmeraldino L. E., Trombone A. P. F., et al. Inhibition of the myotoxic activity of Bothrops jararacussu venom and its two major myotoxins, BthTX-I and BthTX-II, by the aqueous extract of Tabernaemontana catharinensis A. DC. (Apocynaceae) Phytomedicine. 2005;12(1-2):123–130. doi: 10.1016/j.phymed.2003.07.010. [PubMed] [Cross Ref]
127. Núñez V., Otero R., Barona J., et al. Neutralization of the edema-forming, defibrinating and coagulant effects of Bothrops asper venom by extracts of plants used by healers in Columbia. Brazilian Journal of Medical and Biological Research. 2004;37(7):969–977. doi: 10.1590/s0100-879x2004000700005. [PubMed] [Cross Ref]
128. de Moura V. M., de Sousa L. A. F., de Oliveira R. B., et al. Inhibition of the principal enzymatic and biological effects of the crude venom of Bothrops atrox by plant extracts. Journal of Medicinal Plants Research. 2013;7(31):2330–2337. doi: 10.5897/JMPR2013.5148. [Cross Ref]
129. Badilla B., Chaves F., Mora G., Poveda L. J. Edema induced by Bothrops asper (Squamata: Viperidae) snake venom and its inhibition by Costa Rican plant extracts. Revista de Biologia Tropical. 2006;54(2):245–252. [PubMed]
130. Melo P. A., Nascimento M. C. D., Mors W. B., Suarez-Kurtz G. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents. Toxicon. 1994;32(5):595–603. doi: 10.1016/0041-0101(94)90207-0. [PubMed] [Cross Ref]
131. Mourao V. B., Giraldi G. M., Neves L. M. G. Anti-hemorrhagic effect of hydro-alcoholic extract of the leaves of Mikania glomerata in lesions induced by Bothrops jararaca venom in rats. Acta Cirurgica Brasileira. 2014;29(1):30–37. doi: 10.1590/S0102-86502014000100005. [PubMed] [Cross Ref]
132. Motta Y. P., Sakate M., Nogueira R. M. B., et al. Quantification of cytokines in serum and paw homogenate of experimental intoxication for venom of the Bothropoides jararaca in Wistar rats treated with antivenom and Mikania glomerata. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia. 2014;66(5):1413–1418. doi: 10.1590/1678-6829. [Cross Ref]
133. Oliveira D. P. C., Borrás M. R. L., Ferreira L. C. D. L., López-Lozano J. L. Atividade antiinflamatória do extrato aquoso de Arrabidaea chica (Humb. & Bonpl.) B. Verl. sobre o edema induzido por venenos de serpentes amazônicas. Revista Brasileira de Farmacognosia. 2009;19(2B):643–49.
134. Otero R., Núñez V., Jiménez S. L., et al. Snakebites and ethnobotany in the northwest region of Colombia. Part II: Neutralization of lethal and enzymatic effects of Bothrops atrox venom. Journal of Ethnopharmacology. 2000;71(3):505–511. doi: 10.1016/S0378-8741(99)00197-X. [PubMed] [Cross Ref]
135. Ticli F. K., Hage L. I. S., Cambraia R. S., et al. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): Antiserum action potentiation and molecular interaction. Toxicon. 2005;46(3):318–327. doi: 10.1016/j.toxicon.2005.04.023. [PubMed] [Cross Ref]
136. De Oliveira E. C., Anholeti M. C., Domingos T. F., et al. Inhibitory effect of the plant Clusia fluminensis against biological activities of Bothrops jararaca snake venom. Natural Product Communications. 2014;9(1):21–25. [PubMed]
137. Picanço L. C. D. S., Bittencourt J. A. H. M., Henriques S. V. C., et al. Pharmacological activity of Costus spicatus in experimental Bothrops atrox envenomation. Pharmaceutical Biology. 2016;54(10):2103–2110. doi: 10.3109/13880209.2016.1145703. [PubMed] [Cross Ref]
138. Fernandes J. M., Félix-Silva J., Da Cunha L. M., et al. Inhibitory effects of hydroethanolic leaf extracts of kalanchoe brasiliensis and kalanchoepinnata (crassulaceae) against local effects induced by bothropsjararaca snake venom. PLoS ONE. 2016;11(12) doi: 10.1371/journal.pone.0168658.e0168658 [PMC free article] [PubMed] [Cross Ref]
139. Nishijima C. M., Rodrigues C. M., Silva M. A., Lopes-Ferreira M., Vilegas W., Hiruma-Lima C. A. Anti-hemorrhagic activity of four brazilian vegetable species against Bothrops jararaca venom. Molecules. 2009;14(3):1072–1080. doi: 10.3390/molecules14031072. [PubMed] [Cross Ref]
140. Esmeraldino L. E., Souza A. M., Sampaio S. V. Evaluation of the effect of aqueous extract of Croton urucurana Baillon (Euphorbiaceae) on the hemorrhagic activity induced by the venom of Bothrops jararaca, using new techniques to quantify hemorrhagic activity in rat skin. Phytomedicine. 2005;12(8):570–576. doi: 10.1016/j.phymed.2004.01.012. [PubMed] [Cross Ref]
141. Gomes J. A. D. S., Félix-Silva J., Morais Fernandes J., et al. Aqueous Leaf Extract of Jatropha mollissima (Pohl) Bail Decreases Local Effects Induced by Bothropic Venom. BioMed Research International. 2016;2016:13. doi: 10.1155/2016/6101742.6101742 [PMC free article] [PubMed] [Cross Ref]
142. Mack-Wen V. L., Rico L. B., Alarc J. C., Perea J. A., Alarcón J. C. Inhibición in vitro del veneno de Bothrops asper con extractos etanólicos de Brownea ariza B. (Caesalpiniaceae) Vitae. 2011;18(1):43–48.
143. Salazar M., Chérigo L., Acosta H., Otero R., Martínez-Luis S. Evaluation of anti-Bothrops asper venom activity of ethanolic extract of Brownea rosademonte leaves. Acta Pharmaceutica. 2014;64(4):475–483. doi: 10.2478/acph-2014-0033. [PubMed] [Cross Ref]
144. Nazato V. S., Rubem-Mauro L., Vieira N. A. G., et al. In vitro antiophidian properties of Dipteryx alata Vogel bark extracts. Molecules. 2010;15(9):5956–5970. doi: 10.3390/molecules15095956. [PubMed] [Cross Ref]
145. Da Silva J. O., Coppede J. S., Fernandes V. C., et al. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba. Journal of Ethnopharmacology. 2005;100(1-2):145–152. doi: 10.1016/j.jep.2005.01.063. [PubMed] [Cross Ref]
146. Vale L. H. F., Mendes M. M., Hamaguchi A., Soares A. M., Rodrigues V. M., Homsi-Brandeburgo M. I. Neutralization of pharmacological and toxic activities of Bothrops snake venoms by Schizolobium parahyba (Fabaceae) aqueous extract and its fractions. Basic and Clinical Pharmacology and Toxicology. 2008;103(1):104–107. doi: 10.1111/j.1742-7843.2008.00248.x. [PubMed] [Cross Ref]
147. Mendes M. M., Oliveira C. F., Lopes D. S., et al. Anti-snake venom properties of Schizolobium parahyba (caesalpinoideae) aqueous leaves extract. Phytotherapy Research. 2008;22(7):859–866. doi: 10.1002/ptr.2371. [PubMed] [Cross Ref]
148. Perea J. A., Jimenez S. L., Quintana J. C., Pereañez J. A. Inhibición de las actividades proteolítica, coagulante y hemolítica indirecta inducidas por el veneno de Bothrops asper por extractos etanólicos de tres especies de heliconias. Vitae. 2008;15(1):157–164.
149. Assafim M., Coriolano E. C., Benedito S. E. Hypericum brasiliense plant extract neutralizes some biological effects of Bothrops jararaca snake venom. Journal of Venom Research. 2011;2:11–16. [PMC free article] [PubMed]
150. Costa H. N., Santos M. C., Alcântara A. F., Silva M. C., França R. C., Piló-Veloso D. Constituintes químicos e atividade antiedematogênica de Peltodon radicans (Lamiaceae) Química Nova. 2008;31(4):744–750. doi: 10.1590/S0100-40422008000400006. [Cross Ref]
151. Mendes M. M., Vieira S. A. P. B., Gomes M. S. R., et al. Triacontyl p-coumarate: an inhibitor of snake venom metalloproteinases. Phytochemistry. 2013;86:72–82. doi: 10.1016/j.phytochem.2012.10.007. [PubMed] [Cross Ref]
152. de Moura V. M., de Souza L. Y., da Costa Guimarães N., et al. The potential of aqueous extracts of Bellucia dichotoma Cogn. (Melastomataceae) to inhibit the biological activities of Bothrops atrox venom: A comparison of specimens collected in the states of Pará and Amazonas, Brazil. Journal of Ethnopharmacology. 2017;196:168–177. doi: 10.1016/j.jep.2016.12.031. [PubMed] [Cross Ref]
153. Badilla B., Chaves F., Jiménez S., Rodríguez G., Poveda L. J. Effects of an extract of Cissampelos pareira on the hemorrhagic and proteolytic activities from Bothrops asper venom. Pharmacognosy Magazine. 2008;4(13):27–31.
154. Bittencourt J. A. H. M., de Oliveira N. K. S., Cabral M. S., et al. Antiophidian activity of Brosimum guianense (AUBL) Huber. American Journal of Pharmacology and Toxicology. 2014;9(2):148–156. doi: 10.3844/ajptsp.2014.148.156. [Cross Ref]
155. Borges M. H., Alves D. L. F., Raslan D. S., et al. Neutralizing properties of Musa paradisiaca L. (Musaceae) juice on phospholipase A2, myotoxic, hemorrhagic and lethal activities of crotalidae venoms. Journal of Ethnopharmacology. 2005;98(1-2):21–29. doi: 10.1016/j.jep.2004.12.014. [PubMed] [Cross Ref]
156. Sousa L. A. F., Moura V. M., Raposo J. D. A. The effect of the aqueous extract of Myrcia guianensis (AubL) DC and its fractions against the hemorrhagic activity of Bothrops jararaca venom. Journal of Medicinal Plants Research. 2013;7(42):3139–46.
157. Freitas F. G., Silva T. A., Oliveira F. Toxicidade aguda e propriedades antiofídicas do extrato aquoso de Casearia grandiflora (Flacourtiaceae): atividades fosfolipásica A2, miotóxica e letal de peçonhas de B. moojeni e B. neuwiedi. Bioscience Journal. 2005;21(2):95–103.
158. Cintra-Francischinelli M., Silva M. G., Andréo-Filho N., et al. Antibothropic action of casearia sylvestris Sw. (flacourtiaceae) extracts. Phytotherapy Research. 2008;22(6):784–790. doi: 10.1002/ptr.2365. [PubMed] [Cross Ref]
159. Borges M. H., Soares A. M., Rodrigues V. M., et al. Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae) Toxicon. 2001;39(12):1863–1869. doi: 10.1016/S0041-0101(01)00169-6. [PubMed] [Cross Ref]
160. Da Silva S. L., Calgarotto A. K., Chaar J. S., Marangoni S. Isolation and characterization of ellagic acid derivatives isolated from Casearia sylvestris SW aqueous extract with anti-PLA2 activity. Toxicon. 2008;52(6):655–666. doi: 10.1016/j.toxicon.2008.07.011. [PubMed] [Cross Ref]
161. Da Silva M. L., Marcussi S., Fernandes R. S., et al. Anti-snake venom activities of extracts and fractions from callus cultures of Sapindus saponaria. Pharmaceutical Biology. 2012;50(3):366–375. doi: 10.3109/13880209.2011.608072. [PubMed] [Cross Ref]
162. Fernandes R. S., Costa T. R., Marcussi S., et al. Neutralization of pharmacological and toxic activities of Bothrops jararacussu snake venom and isolated myotoxins by Serjania erecta methanolic extract and its fractions. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2011;17(1):85–93. doi: 10.1590/S1678-91992011000100011. [Cross Ref]
163. Tribuiani N., da Silva A. M., Ferraz M. C., et al. Vellozia flavicans Mart. ex Schult. hydroalcoholic extract inhibits the neuromuscular blockade induced by Bothrops jararacussu venom. BMC Complementary and Alternative Medicine. 2014;14, article 48 doi: 10.1186/1472-6882-14-48. [PMC free article] [PubMed] [Cross Ref]
164. Melo M. M., Lúcia M., Habermehl G. G. Plant extracts for topic therapy of Bothrops alternatus envenomation. Brazilian Journal of Pharmacognosy. 2007;17(1):29–34. doi: 10.1590/S0102-695X2007000100007. [Cross Ref]
165. Fernández M., Ortiz W. F., Pereáñez J. A., Martínez D. Evaluación de las propiedades antiofídicas del extracto etanólico y fracciones obtenidas de Renealmia alpinia(Rottb) Mass (Zingiberaceae) cultivada in vitro. Vitae. 2010;17(1):75–82.
166. Patiño A. C., López J., Aristizábal M., Quintana J. C., Benjumea D. Evaluation of the inhibitory effect of extracts from leaves of renealmia alpinia rottb. maas(Zingiberaceae) on the venom of bothrops asper (mapaná) Biomedica. 2012;32(3):365–374. doi: 10.7705/biomedica.v32i3.591. [PubMed] [Cross Ref]
167. Ode O. J., Asuzu I. U. The anti-snake venom activities of the methanolic extract of the bulb of Crinum jagus (Amaryllidaceae) Toxicon. 2006;48(3):331–342. doi: 10.1016/j.toxicon.2006.06.003. [PubMed] [Cross Ref]
168. Gutiérrez J. M., Rucavado A., Chaves F., Díaz C., Escalante T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon. 2009;54(7):958–975. doi: 10.1016/j.toxicon.2009.01.038. [PubMed] [Cross Ref]
169. Paixão-Cavalcante D., Kuniyoshi A. K., Portaro F. C. V., da Silva W. D., Tambourgi D. V. African Adders: Partial Characterization of Snake Venoms from Three Bitis Species of Medical Importance and Their Neutralization by Experimental Equine Antivenoms. PLoS Neglected Tropical Diseases. 2015;9(2) doi: 10.1371/journal.pntd.0003419.e0003419 [PMC free article] [PubMed] [Cross Ref]
170. Ushanandini S., Nagaraju S., Nayaka S. C., Kumar K. H., Kemparaju K., Girish K. S. The anti-ophidian properties of Anacardium occidentale bark extract. Immunopharmacology and Immunotoxicology. 2009;31(4):607–615. doi: 10.3109/08923970902911909. [PubMed] [Cross Ref]
171. Dhananjaya B. L., Zameer F., Girish K. S., D'Souza C. J. M. Anti-venom potential of aqueous extract of stem bark of Mangifera indica L. against Daboia russellii (Russell's viper) venom. Indian Journal of Biochemistry and Biophysics. 2011;48(3):175–183. [PubMed]
172. Alam M. I., Auddy B., Gomes A. Viper venom neutralization by Indian medicinal plant (Hemidesmus indicus and Pluchea indica) root extracts. Phytotherapy Research. 1996;10(1):58–61. doi: 10.1002/(SICI)1099-1573(199602)10:1<58::AID-PTR775>3.0.CO;2-F. doi: 10.1002/(SICI)1099-1573(199602)10:1<58::AID-PTR775>3.0.CO;2-F. [Cross Ref]
173. Bhattacharjee P., Bhattacharyya D. Characterization of the aqueous extract of the root of Aristolochia indica: evaluation of its traditional use as an antidote for snake bites. Journal of Ethnopharmacology. 2013;145(1):220–226. doi: 10.1016/j.jep.2012.10.056. [PubMed] [Cross Ref]
174. Shirwaikar A., Rajendran K., Bodla R., Kumar C. D. Neutralization potential of Viper russelli russelli (Russell's viper) venom by ethanol leaf extract of Acalypha indica. Journal of Ethnopharmacology. 2004;94(2-3):267–273. doi: 10.1016/j.jep.2004.05.010. [PubMed] [Cross Ref]
175. Tarannum S., Mohamed R., Vishwanath B. S. Inhibition of testicular and Vipera russelli snake venom hyaluronidase activity by Butea monosperma (Lam) Kuntze stem bark. Natural Product Research. 2012;26(18):1708–1711. doi: 10.1080/14786419.2011.602829. [PubMed] [Cross Ref]
176. Maung K. M., Lynn Z. Effects of Tamarind (Tamarindus indicus Linn) seed extract on Russell's viper (Daboia russelli siamensis) venom. Tropical Biomedicine. 2012;29(4):580–587. [PubMed]
177. Ushanandini S., Nagaraju S., Kumar K. H., et al. The anti-snake venom properties of Tamarindus indica (leguminosae) seed extract. Phytotherapy Research. 2006;20(10):851–858. doi: 10.1002/ptr.1951. [PubMed] [Cross Ref]
178. Alam M. I., Gomes A. Snake venom neutralization by Indian medicinal plants (Vitex negundo and Emblica officinalis) root extracts. Journal of Ethnopharmacology. 2003;86(1):75–80. doi: 10.1016/s0378-8741(03)00049-7. [PubMed] [Cross Ref]
179. Chandrashekara K. T., Nagaraju S., Usha Nandini S., Basavaiah, Kemparaju K. Neutralization of local and systemic toxicity of Daboia russelii venom by Morus alba plant leaf extract. Phytotherapy Research. 2009;23(8):1082–1087. doi: 10.1002/ptr.2735. [PubMed] [Cross Ref]
180. Krishnan S. A., Dileepkumar R., Nair A. S., Oommen O. V. Studies on neutralizing effect of Ophiorrhiza mungos root extract against Daboia russelii venom. Journal of Ethnopharmacology. 2014;151(1):543–547. doi: 10.1016/j.jep.2013.11.010. [PubMed] [Cross Ref]
181. Janardhan B., Shrikanth V. M., Mirajkar K. K., More S. S. In vitro screening and evaluation of antivenom phytochemicals from Azima tetracantha Lam. leaves against bungarus caeruleus and Vipera russelli. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2014;20(1, article 12) doi: 10.1186/1678-9199-20-12. [PMC free article] [PubMed] [Cross Ref]
182. Mahadeswaraswamy Y. H., Devaraja S., Kumar M. S., Goutham Y. N. J., Kemparaju K. Inhibition of local effects of Indian Daboia/Vipera russelli venom by the methanolic extract of grape (Vitis vinifera L.) seeds. Indian Journal of Biochemistry and Biophysics. 2009;46(2):154–160. [PubMed]
183. Mukherjee A. K., Kalita B., Mackessy S. P. A proteomic analysis of Pakistan Daboia russelii russelii venom and assessment of potency of Indian polyvalent and monovalent antivenom. Journal of Proteomics. 2016;144:73–86. doi: 10.1016/j.jprot.2016.06.001. [PubMed] [Cross Ref]
184. Wüster W. The genus Daboia (Serpentes: Viperidae): Russell's viper. Hamadryad. 1998;23(1):33–40.
185. Warrell D. A. Snake bite. The Lancet. 2010;375(9708):77–88. doi: 10.1016/S0140-6736(09)61754-2. [PubMed] [Cross Ref]
186. Pla D., Sanz L., Molina-Sánchez P., et al. Snake venomics of Lachesis muta rhombeata and genus-wide antivenomics assessment of the paraspecific immunoreactivity of two antivenoms evidence the high compositional and immunological conservation across Lachesis. Journal of Proteomics. 2013;89:112–123. doi: 10.1016/j.jprot.2013.05.028. [PubMed] [Cross Ref]
187. Gutiérrez J. M. Comprendiendo los venenos de serpientes: 50 Años de investigaciones en América Latina. Revista de Biologia Tropical. 2002;50(2):377–394. [PubMed]
188. de Paula R. C., Sanchez E. F., Costa T. R., et al. Antiophidian properties of plant extracts against Lachesis muta venom. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2010;16(2):311–323.
189. De Oliveira E. C., Cruz R. A. S., Amorim N. D. M., et al. Protective effect of the plant extracts of erythroxylum sp. against toxic effects induced by the venom of lachesis muta snake. Molecules. 2016;21(10, article 1350) doi: 10.3390/molecules21101350. [PubMed] [Cross Ref]
190. Biondo R., Soares A. M., Bertoni B. W., França S. C., Pereira A. M. S. Direct organogenesis of Mandevilla illustris (Vell) Woodson and effects of its aqueous extract on the enzymatic and toxic activities of Crotalus durissus terrificus snake venom. Plant Cell Reports. 2004;22(8):549–552. doi: 10.1007/s00299-003-0722-6. [PubMed] [Cross Ref]
191. Ode O. J., Nwaehujor C. O., Onakpa M. M. Evaluation of antihaemorrhagic and antioxidant potentials of Crinum jagus bulb. International Journal of Applied Biology and Pharmaceutical Technology. 2010;1(3):1330–1336.
192. Nalbantsoy A., Erel Ş. B., Köksal Ç., Göçmen B., Yildiz M. Z., Karabay Yavaşoĝlu N. Ü. Viper venom induced inflammation with Montivipera xanthina (Gray, 1849) and the anti-snake venom activities of Artemisia absinthium L. in rat. Toxicon. 2013;65:34–40. doi: 10.1016/j.toxicon.2012.12.017. [PubMed] [Cross Ref]
193. Collaço R. D. C. O., Cogo J. C., Rodrigues-Simioni L., Rocha T., Oshima-Franco Y., Randazzo-Moura P. Protection by Mikania laevigata (guaco) extract against the toxicity of Philodryas olfersii snake venom. Toxicon. 2012;60(4):614–622. doi: 10.1016/j.toxicon.2012.05.014. [PubMed] [Cross Ref]
194. Amog P. U., Manjuprasanna V. N., Yariswamy M., et al. Albizia lebbeck seed methanolic extract as a complementary therapy to manage local toxicity of Echis carinatus venom in a murine model. Pharmaceutical Biology. 2016;54(11):2568–2574. doi: 10.3109/13880209.2016.1171882. [PubMed] [Cross Ref]
195. Nanjaraj Urs A. N., Yariswamy M., Joshi V., et al. Local and systemic toxicity of Echis carinatus venom: Neutralization by Cassia auriculata L. leaf methanol extract. Journal of Natural Medicines. 2014;69(1):111–122. doi: 10.1007/s11418-014-0875-3. [PubMed] [Cross Ref]
196. Hasson S. S., Al-Balushi M. S., Said E. A., et al. Neutralisation of local haemorrhage induced by the saw-scaled viper Echis carinatus sochureki venom using ethanolic extract of Hibiscus aethiopicus L. Evidence-Based Complementary and Alternative Medicine. 2012;2012:8. doi: 10.1155/2012/540671.540671 [PMC free article] [PubMed] [Cross Ref]
197. Hasson S. S., Al-Jabri A. A., Sallam T. A., Al-Balushi M. S., Mothana R. A. A. Antisnake venom activity of hibiscus aethiopicus L. against echis ocellatus and naja n. nigricollis. Journal of Toxicology. 2010;2010 doi: 10.1155/2010/837864.837864 [PMC free article] [PubMed] [Cross Ref]
198. Mahadeswaraswamy Y. H., Nagaraju S., Girish K. S., Kemparaju K. Local tissue destruction and procoagulation properties of Echis carinatus venom: Inhibition by Vitis vinifera seed methanol extract. Phytotherapy Research. 2008;22(7):963–969. doi: 10.1002/ptr.2462. [PubMed] [Cross Ref]
199. Boldrini-França J., Corrêa-Netto C., Silva M. M. S., et al. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: Assessment of geographic variation and its implication on snakebite management. Journal of Proteomics. 2010;73(9):1758–1776. doi: 10.1016/j.jprot.2010.06.001. [PubMed] [Cross Ref]
200. Santoro M. L., Sousa-E-Silva M. C. C., Gonçalves L. R. C., et al. Comparison of the biological activities in venoms from three subspecies of the South American rattlesnake (Crotalus durissus terrificus, C. durissus cascavella and C. durissus collilineatus) Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology. 1999;122(1):61–73. doi: 10.1016/S0742-8413(98)10079-8. [PubMed] [Cross Ref]
201. Sangiorgio F., Sakate M., Nogueira R. M. B., Araújo J. P., Jr., Chavez-Olortegui C. Kinetics of venom and antivenom serum levels, clinical evaluation and therapeutic effectiveness in dogs inoculated with Crotalus durissus terrificus venom. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2008;14(1):100–112.
202. Hiremath V., Nanjaraj Urs A. N., Joshi V., et al. Differential action of medically important Indian BIG FOUR snake venoms on rodent blood coagulation. Toxicon. 2016;110:19–26. doi: 10.1016/j.toxicon.2015.11.014. [PubMed] [Cross Ref]
203. Chen Q., Wang W., Li Q., Bai Y., Zou X., Wu Y. Effect of externally applied Jidesheng anti-venom on skin and soft-tissue necrosis after Chinese cobra bite: a retrospective study. Journal of Traditional Chinese Medicine. 2014;34(2):150–154. doi: 10.1016/S0254-6272(14)60069-8. [PubMed] [Cross Ref]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Hindawi